Sanara Medtech Inc (SMTI) — Capital Reinvestment Ratio
Latest as of December 2025:
0.02x
Sanara Medtech Inc (SMTI) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow ($3.95 Million) in capital expenditures ($82.16K). See Sanara Medtech Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
$3.95 Million
USD
Capital Expenditures
$82.16K
USD
Data as of
Dec 2025
Most recent filing
Sanara Medtech Inc Capital Reinvestment Ratio (2016–2025)
This chart tracks Sanara Medtech Inc's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Sanara Medtech Inc (2016–2025)
Year-by-year Capital Reinvestment Ratio for Sanara Medtech Inc from 2016 to 2025. For live market cap and broader valuation context, see SMTI market cap.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.68x | $6.79 Million | $4.63 Million | ▲ +2127.0% |
| 2018 | 0.03x | $277.14K | $8.48K | ▲ +313.5% |
| 2016 | 0.01x | $409.25K | $3.03K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow